Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules

ZX He, YP Gong, X Zhang, LY Ma, W Zhao - European journal of medicinal …, 2021 - Elsevier
Identification of potent anticancer agents with high selectivity and low toxicity remains on the
way to human health. Pyridazine featuring advantageous physicochemical properties and …

Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents-A recent update

PG Jain, BD Patel - European journal of medicinal chemistry, 2019 - Elsevier
Abstract Poly (ADP-ribose) Polymerase1 (PARP1) is a member of 17 membered PARP
family having diversified biological functions such as synthetic lethality, DNA repair …

Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents

MA El-Zahabi, H Sakr, K El-Adl, M Zayed… - Bioorganic …, 2020 - Elsevier
Thalidomide and its analogs are immunomodulatory drugs that inhibit the production of
certain inflammatory mediators associated with cancer. In the present work, a new series of …

Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma

IH Eissa, MK Ibrahim, AM Metwaly, A Belal… - Bioorganic …, 2021 - Elsevier
A series of new VEGFR-2 inhibitors were designed, synthesized and evaluated for their anti-
proliferative activities against hepatocellular carcinoma (HepG-2 cell line). Compound 29 b …

[HTML][HTML] 1, 3, 4-Oxadiazole-containing hybrids as potential anticancer agents: Recent developments, mechanism of action and structure-activity relationships

S Nayak, SL Gaonkar, EA Musad… - Journal of Saudi Chemical …, 2021 - Elsevier
Chemotherapy is an important therapeutic approach for the treatment of cancer. Currently,
many anticancer drugs are available in the market that plays an important role in cancer …

Selective PARP1 inhibitors, PARP1-based dual-target inhibitors, PROTAC PARP1 degraders, and prodrugs of PARP1 inhibitors for cancer therapy

X Peng, W Pan, F Jiang, W Chen, Z Qi, W Peng… - Pharmacological …, 2022 - Elsevier
Poly ADP-ribose polymerase (PARP) plays a critical role in many cellular processes such as
DNA damage repair, gene transcription and cell apoptosis. Therefore, targeting PARP …

Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies

A Sabt, OM Abdelhafez, RS El-Haggar… - Journal of enzyme …, 2018 - Taylor & Francis
Herein, we report the synthesis of different novel sets of coumarin-6-sulfonamide derivatives
bearing different functionalities (4a, b, 8a–d, 11a–d, 13a, b, and 15a–c), and in vitro …

Multi-therapies based on PARP inhibition: potential therapeutic approaches for cancer treatment

J Zhang, Y Gao, Z Zhang, J Zhao, W Jia… - Journal of Medicinal …, 2022 - ACS Publications
The nuclear enzymes called poly (ADP-ribose) polymerases (PARPs) are known to catalyze
the process of PARylation, which plays a vital role in various cellular functions. They have …

Synthesis and in vitro anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas as apoptosis-inducing agents

WM Eldehna, GS Hassan, ST Al-Rashood… - Journal of enzyme …, 2019 - Taylor & Francis
In connection with our research program on the development of novel anticancer
candidates, herein we report the design and synthesis of novel series of 1-(2-methyl-6 …

Terminalia chebula Polyphenol and Near-Infrared Dye-Loaded Poly(lactic acid) Nanoparticles for Imaging and Photothermal Therapy of Cancer Cells

M Pebam, R PS, M Gangopadhyay… - ACS Applied Bio …, 2022 - ACS Publications
Photothermal/photodynamic therapies (PTT/PDT) are multimodal approaches employing
near-infrared (NIR) light-responsive photosensitizers for cancer treatment. In the current …